The First Trust NYSE Arca Biotechnology UCITS ETF, trading under the ticker DE:1FU6, is a specialized investment vehicle designed for those seeking targeted exposure within the dynamic health care sector. This ETF zeroes in on the biotechnology niche, a frontier of medical innovation where groundbreaking developments shape the future of health care. By investing in this fund, investors gain access to a curated portfolio of companies at the forefront of biotech advancements, ranging from genetic sequencing to cutting-edge pharmaceuticals and beyond. This ETF is not only a gateway to potential high-growth opportunities but also a means to align one's investment strategy with the rapidly evolving landscape of biotechnology. Suitable for investors with a keen interest in health care innovations, the First Trust NYSE Arca Biotechnology UCITS ETF offers a strategic approach to capturing the potential upside of the biotech revolution while navigating the complexities of this specialized market.
First Trust NYSE Arca Biotechnology UCITS ETF (1FU6) Fund Flow Chart
First Trust NYSE Arca Biotechnology UCITS ETF (1FU6) 1 year Net Flows: €2M
For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.